Pilot Randomized Trial of an Educational Intervention About Immunotherapy for Patients With Advanced Cancer and Their Caregivers
A novel educational intervention about ICI risks and benefits was feasible to deliver, deemed acceptable, and shows promise in improving knowledge and activation to ask questions without increasing anxiety. A future study evaluating UPLIFT's efficacy in these and other outcomes, including severe ICI toxicity, is warranted.
Authors
- Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5344-6645)
- Jennifer S. Temel (ORCID: https://orcid.org/0000-0002-7268-5921)
- Laura A. Petrillo (ORCID: https://orcid.org/0000-0002-8721-4858)
- Kerry L. Reynolds (ORCID: https://orcid.org/0000-0002-7793-654X)
- Kelly Hsu (ORCID: https://orcid.org/0000-0003-2885-6946)
- Ashley Zhou (ORCID: https://orcid.org/0000-0002-3678-1166)
- Joseph A. Greer (ORCID: https://orcid.org/0000-0002-0979-4076)
- Angelo E. Volandes
- An Tran (ORCID: https://orcid.org/0000-0002-0677-3915)
- Areej El‐Jawahri (ORCID: https://orcid.org/0000-0002-3556-1495)
- Roshni Sarathy
- Dustin J. Rabideau (ORCID: https://orcid.org/0000-0002-3829-7079)
- Kedie Pintro
Institutions
- Tufts University (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Health Decisions (United States) (US)
- Columbia University (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-02-01
- DOI
- https://doi.org/10.6004/jnccn.2024.7079
- Citations
- 2
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 6.99